DE69920915D1 - Monophosphoryllipid a enthaltende adjuvans- und impfstoffzusammensetzungen - Google Patents

Monophosphoryllipid a enthaltende adjuvans- und impfstoffzusammensetzungen

Info

Publication number
DE69920915D1
DE69920915D1 DE69920915T DE69920915T DE69920915D1 DE 69920915 D1 DE69920915 D1 DE 69920915D1 DE 69920915 T DE69920915 T DE 69920915T DE 69920915 T DE69920915 T DE 69920915T DE 69920915 D1 DE69920915 D1 DE 69920915D1
Authority
DE
Germany
Prior art keywords
vaccine compositions
monophosphoryllipide
adjuvane
reform
thawed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69920915T
Other languages
English (en)
Other versions
DE69920915T2 (de
Inventor
James Laposta
Hayward Eldridge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Wyeth LLC
Original Assignee
Wyeth Holdings LLC
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Holdings LLC, Wyeth LLC filed Critical Wyeth Holdings LLC
Application granted granted Critical
Publication of DE69920915D1 publication Critical patent/DE69920915D1/de
Publication of DE69920915T2 publication Critical patent/DE69920915T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
DE69920915T 1998-07-14 1999-07-13 Monophosphoryllipid a enthaltende adjuvans- und impfstoffzusammensetzungen Expired - Lifetime DE69920915T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11539298A 1998-07-14 1998-07-14
US115392 1998-07-14
PCT/US1999/015942 WO2000003744A2 (en) 1998-07-14 1999-07-13 Adjuvant and vaccine compositions containing monophosphoryl lipid a

Publications (2)

Publication Number Publication Date
DE69920915D1 true DE69920915D1 (de) 2004-11-11
DE69920915T2 DE69920915T2 (de) 2006-02-16

Family

ID=22361090

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69920915T Expired - Lifetime DE69920915T2 (de) 1998-07-14 1999-07-13 Monophosphoryllipid a enthaltende adjuvans- und impfstoffzusammensetzungen

Country Status (14)

Country Link
EP (1) EP1096954B1 (de)
JP (1) JP2002520373A (de)
KR (1) KR100586804B1 (de)
CN (1) CN1247262C (de)
AT (1) ATE278420T1 (de)
AU (1) AU763770B2 (de)
BR (1) BR9912067A (de)
CA (1) CA2333578C (de)
DE (1) DE69920915T2 (de)
DK (1) DK1096954T3 (de)
ES (1) ES2229745T3 (de)
IL (1) IL140890A0 (de)
PT (1) PT1096954E (de)
WO (1) WO2000003744A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
HUP0104825A3 (en) 1998-12-22 2008-04-28 Microscience Ltd Genes and proteins, and their use
MXPA02011486A (es) * 2000-05-19 2004-01-26 Corixa Corp Tratamiento profilactico y terapeutico de enfermedades infecciosas, autoinmunes y alergicas con compuestos a base de mono y disacarido.
FR2814956B1 (fr) 2000-10-06 2003-01-24 Seppic Sa Nouvelle composition vaccinale, procede pour sa preparation, utilisation comme composition injectale en medecine humaine ou veterinaire et nouveau procede de conservation
PL1909830T3 (pl) * 2005-08-02 2012-02-29 Novartis Vaccines And Diagnostics S R L Ograniczenie oddziaływania pomiędzy olejem w adiuwancie a środkiem powierzchniowo czynnym w antygenie
JP6109165B2 (ja) * 2011-07-01 2017-04-05 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア ヘルペスウイルスワクチンおよび使用方法
US9241988B2 (en) 2012-04-12 2016-01-26 Avanti Polar Lipids, Inc. Disaccharide synthetic lipid compounds and uses thereof
EA032441B1 (ru) * 2013-09-05 2019-05-31 Иммьюн Дизайн Корп. Вакцинные композиции против никотиновой зависимости
WO2023212702A2 (en) * 2022-04-28 2023-11-02 Kansas State University Research Foundation Corralling amphipathic peptide colloids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2672496B3 (fr) * 1990-07-18 1993-05-28 Vacsyn France Sa Compositions a base de substances hydrophobes, solubilisables dans un solvant aqueux, leur procede d'obtention, et leurs utilisations notamment dans le domaine pharmaceutique.
ATE204762T1 (de) * 1993-03-23 2001-09-15 Smithkline Beecham Biolog 3-0-deazylierte monophosphoryl lipid a enthaltende impfstoff-zusammensetzungen
US5565204A (en) * 1994-08-24 1996-10-15 American Cyanamid Company Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
US5762943A (en) * 1996-05-14 1998-06-09 Ribi Immunochem Research, Inc. Methods of treating type I hypersensitivity using monophosphoryl lipid A
GB9612137D0 (en) * 1996-06-10 1996-08-14 Quaker Oats Co Treatment of dried fruit
CN1150001C (zh) * 1996-07-03 2004-05-19 卫材株式会社 含有脂质a类似物的注射剂及其制备方法

Also Published As

Publication number Publication date
BR9912067A (pt) 2001-04-10
CA2333578C (en) 2010-11-16
ATE278420T1 (de) 2004-10-15
KR20010071637A (ko) 2001-07-28
IL140890A0 (en) 2002-02-10
EP1096954B1 (de) 2004-10-06
PT1096954E (pt) 2004-12-31
AU5101899A (en) 2000-02-07
ES2229745T3 (es) 2005-04-16
WO2000003744A3 (en) 2000-04-27
CA2333578A1 (en) 2000-01-27
WO2000003744A2 (en) 2000-01-27
AU763770B2 (en) 2003-07-31
EP1096954A2 (de) 2001-05-09
DE69920915T2 (de) 2006-02-16
JP2002520373A (ja) 2002-07-09
CN1307483A (zh) 2001-08-08
DK1096954T3 (da) 2005-01-31
KR100586804B1 (ko) 2006-06-07
CN1247262C (zh) 2006-03-29

Similar Documents

Publication Publication Date Title
IS5329A (is) Flutningskerfi fyrir antígen þar sem monoglýseríðeða díglýseríð afleiður eru ónæmisglæðar
WO2003039330A3 (en) Devices and methods to correct spinal deformities
NZ508110A (en) Attenuated mutants of salmonella which constitutively express the Vi antigen
NZ513202A (en) Antigen composition comprising Bordetella bronchiseptica, formalin and glutaraldehyde
IL140710A0 (en) Pulmonary delivery of active agents
ATE238415T1 (de) Feste phytase-zusammensetzungen
NO20002741L (no) Vaksine-blandinger omfattende kitosan, for mukosal administrasjon
DK1096954T3 (da) Adjuvans- og vaccinesammensætninger indeholdende monophosphoryllipid A
ATE210995T1 (de) Interleukin-11 präparat
JO2386B1 (en) Dispersing compounds containing lipase inhibitors
BR0011030A (pt) Composições de cicloporina substancialmente livre de óleo
DE69634024D1 (de) Adjuvans für vitale Impfstoffe
CA2177667A1 (en) Mammalian vaccine compositions comprising squalene or squalane, lecithin and a polyoxyethylene sorbitan ester as an adjuvant
BG103914A (en) Maintained separation of delayed gels
MXPA01003501A (es) Metodo para moderar el estres o tension de las plantas.
WO2000033887A3 (en) Methods and formulations for reducing circulating antibodies
AU2001258373A1 (en) Method for identifying helicobacter antigens
WO2002017858A3 (en) Role of fosb in bone formation
CA2442698A1 (en) Thermolabile liposome with controlled release temperature
BG105372A (en) Immunogenic liposome compositions
AR016514A1 (es) Composicion para mejorar el malestar estomacal, metodo para preparar dicha composicion y metodo para utilizarla
MXPA05009447A (es) Vacunas bovinas con adyuvante.
WO2003006645A3 (en) Method and composition for inhibiting heparanase activity
DE69905915D1 (de) Triaryl phosphatesterzusammensetzung
MXPA03001440A (es) Compuestos de trioxepano novedosos.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition